Table 3. Time to Breakeven and Net Costs for Full and Diabetes Samples.
|
Time to Breakeven (Years) |
5-year Net Costs (United States Dollars) |
|||
|---|---|---|---|---|
|
Morbid Obese Sample
| ||||
| Sample | LAGB | LRYGB | LAGB | LRYGB |
| Full sample | 1.5 (1.45 1.55) | 2.25 (2.07 2.43) | −78,980 (−100,550-62,320) | −61,420 (−82,870-44,710) |
| Diabetes subsample | 1.25 (1.02 1.48) | 1.75 (1.49 2.01) | −127,590 (−167,590-94,840) | −103,340 (−146,760-65,550) |
| Random Sample | ||||
| Sample | LAGB | LRYGB | LAGB | LRYGB |
| Full sample | 5.25 (4.25 10+) | 10+ | 690 (−6,800 8,400) | 18,940 (10,390 26,740) |
| Diabetes subsample | 4.25 (3 10+) | 10+ | −3,060 (−13,230 7,930) | 21,610 (3,330 42,570) |
Note: LAGB = laparoscopic adjustable gastric band; LRYGB = Laparoscopic Roux-en-Y Bypass